IGFBP-2 Vaccine and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Undergoing Surgery

NCT03029611 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

11

Enrollment

OTHER

Sponsor class

Stopped Terminated due to lack of funding

Conditions

Stage III Fallopian Tube Cancer
Stage III Ovarian Cancer
Stage III Primary Peritoneal Cancer
Stage IIIA Fallopian Tube Cancer
Stage IIIA Ovarian Cancer
Stage IIIA Primary Peritoneal Cancer
Stage IIIB Fallopian Tube Cancer
Stage IIIB Ovarian Cancer
Stage IIIB Primary Peritoneal Cancer
Stage IIIC Fallopian Tube Cancer
Stage IIIC Ovarian Cancer
Stage IIIC Primary Peritoneal Cancer
Stage IV Fallopian Tube Cancer
Stage IV Ovarian Cancer
Stage IV Primary Peritoneal Cancer

Interventions

DRUG: Carboplatin
PROCEDURE: Gynecological Surgical Procedure
OTHER: Laboratory Biomarker Analysis
DRUG: Paclitaxel
BIOLOGICAL: pUMVC3-hIGFBP-2 Multi-Epitope Plasmid DNA Vaccine

Sponsor

University of Washington

Collaborators

[object Object]